{"id":"NCT00314574","sponsor":"Genentech, Inc.","briefTitle":"A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)","officialTitle":"A Phase IIIb Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Xolair in Subjects With Moderate to Severe Persistent Asthma Who Are Inadequately Controlled With High-Dose Inhaled Corticosteroids and Long-Acting Beta-Agonists","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-12","primaryCompletion":"2009-11","completion":"2009-11","firstPosted":"2006-04-14","resultsPosted":"2011-10-13","lastUpdate":"2012-02-09"},"enrollment":850,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"omalizumab (Xolair)","otherNames":["Xolair"]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"corticosteroids","otherNames":[]},{"type":"DRUG","name":"long-acting beta-agonists","otherNames":[]}],"arms":[{"label":"Xolair","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicenter, randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of subcutaneously administered Xolair as add-on therapy for the treatment of subjects aged 12-75 years old diagnosed with moderate to severe asthma who are inadequately controlled with high-dose inhaled corticosteroids (ICS)+ long-acting beta-agonists (LABA) with or without additional controller therapy.","primaryOutcome":{"measure":"Rate of Asthma Exacerbations Over the 48 Week Treatment Period","timeFrame":"48 weeks","effectByArm":[{"arm":"Placebo","deltaMin":0.88,"sd":null},{"arm":"Xolair","deltaMin":0.66,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":11},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["34303017","33465457","33223095","33217063","31760132","23471469","21536936"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":44,"n":420},"commonTop":["upper respiratory infection","sinusitis","bronchitis","headache","nasopharyngitis"]}}